BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 24378873)

  • 21. Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle.
    Smith IJ; Aversa Z; Alamdari N; Petkova V; Hasselgren PO
    J Cell Biochem; 2010 Nov; 111(4):1059-73. PubMed ID: 20677217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting myostatin/activin A protects against skeletal muscle and bone loss during spaceflight.
    Lee SJ; Lehar A; Meir JU; Koch C; Morgan A; Warren LE; Rydzik R; Youngstrom DW; Chandok H; George J; Gogain J; Michaud M; Stoklasek TA; Liu Y; Germain-Lee EL
    Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23942-23951. PubMed ID: 32900939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
    Wang H; Lai YJ; Chan YL; Li TL; Wu CJ
    Cancer Lett; 2011 Jun; 305(1):40-9. PubMed ID: 21397390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle NAD
    Hulmi JJ; Penna F; Pöllänen N; Nissinen TA; Hentilä J; Euro L; Lautaoja JH; Ballarò R; Soliymani R; Baumann M; Ritvos O; Pirinen E; Lalowski M
    Mol Metab; 2020 Nov; 41():101046. PubMed ID: 32599075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rikkunshito ameliorates cachexia associated with bleomycin-induced lung fibrosis in mice by stimulating ghrelin secretion.
    Tsubouchi H; Yanagi S; Miura A; Mogami S; Yamada C; Iizuka S; Hattori T; Nakazato M
    Nutr Res; 2014 Oct; 34(10):876-85. PubMed ID: 25270999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
    Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
    Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle myostatin signalling is enhanced in experimental cancer cachexia.
    Costelli P; Muscaritoli M; Bonetto A; Penna F; Reffo P; Bossola M; Bonelli G; Doglietto GB; Baccino FM; Rossi Fanelli F
    Eur J Clin Invest; 2008 Jul; 38(7):531-8. PubMed ID: 18578694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle.
    D'Orlando C; Marzetti E; François S; Lorenzi M; Conti V; di Stasio E; Rosa F; Brunelli S; Doglietto GB; Pacelli F; Bossola M
    Muscle Nerve; 2014 Apr; 49(4):528-33. PubMed ID: 23835743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activin A-Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male Mice.
    Walton KL; Chen JL; Arnold Q; Kelly E; La M; Lu L; Lovrecz G; Hagg A; Colgan TD; Qian H; Gregorevic P; Harrison CA
    Endocrinology; 2019 Oct; 160(10):2417-2426. PubMed ID: 31322699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum Activin A in chronic obstructive pulmonary disease with skeletal muscle wasting.
    Zhou G; Gui X; Chen R; Fu X; Ji X; Ding H
    Clinics (Sao Paulo); 2019; 74():e981. PubMed ID: 31271588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mice overexpressing growth hormone exhibit increased skeletal muscle myostatin and MuRF1 with attenuation of muscle mass.
    Consitt LA; Saneda A; Saxena G; List EO; Kopchick JJ
    Skelet Muscle; 2017 Sep; 7(1):17. PubMed ID: 28870245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photobiomodulation therapy moderates cancer cachexia-associated muscle wasting through activating PI3K/AKT/FoxO3a pathway.
    Li Y; Chen Y; Liao Y; Huang T; Tang Q; He C; Xu L; Chang H; Li H; Liu Q; Lai D; Xia Q; Zou Z
    Apoptosis; 2024 Jun; 29(5-6):663-680. PubMed ID: 38598070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Effects of IL6 and Activin A in the Development of Cancer-Associated Cachexia.
    Chen JL; Walton KL; Qian H; Colgan TD; Hagg A; Watt MJ; Harrison CA; Gregorevic P
    Cancer Res; 2016 Sep; 76(18):5372-82. PubMed ID: 27328730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?
    Fontes-Oliveira CC; Busquets S; Toledo M; Penna F; Paz Aylwin M; Sirisi S; Silva AP; Orpí M; García A; Sette A; Inês Genovese M; Olivan M; López-Soriano FJ; Argilés JM
    Biochim Biophys Acta; 2013 Mar; 1830(3):2770-8. PubMed ID: 23200745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy.
    Liu M; Hammers DW; Barton ER; Sweeney HL
    PLoS One; 2016; 11(11):e0166803. PubMed ID: 27870893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin-β(c) reduces reproductive tumour progression and abolishes cancer-associated cachexia in inhibin-deficient mice.
    Gold E; Marino FE; Harrison C; Makanji Y; Risbridger G
    J Pathol; 2013 Mar; 229(4):599-607. PubMed ID: 23180294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise restores decreased physical activity levels and increases markers of autophagy and oxidative capacity in myostatin/activin-blocked mdx mice.
    Hulmi JJ; Oliveira BM; Silvennoinen M; Hoogaars WM; Pasternack A; Kainulainen H; Ritvos O
    Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E171-82. PubMed ID: 23695214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
    Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
    Toledo M; Busquets S; Penna F; Zhou X; Marmonti E; Betancourt A; Massa D; López-Soriano FJ; Han HQ; Argilés JM
    Int J Cancer; 2016 Apr; 138(8):2021-9. PubMed ID: 26595367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.